FDA Brief

Company record

LeMaitre Vascular, Inc.

1 FDA warning letter since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about LeMaitre Vascular, Inc..

Warning letters

  1. LeMaitre Vascular, Inc.

    LeMaitre Vascular's Artegraft graft plant in New Jersey drew an FDA warning letter for water, sterilization and recall-reporting failures.

    High risk

Recalls

ReportedClassFirmProduct and reason
Oct 14 Class II LeMaitre Vascular, Inc.
Device
TufTex¿ Over-the-Wire Embolectomy Catheter; Catalog Number: E1651-88;
Devices failed in process testing related to the amount of pull force it can sustain prior to the balloon components failing.
Mar 25 Class II LeMaitre Vascular, Inc.
Device
Artegraft Vascular Graft; REF#: AG740;
Labeling mix-up resulting in the incorrect lot outer packaging of product.